JPRN-UMIN000015402
Not yet recruiting
未知
Effects of a SGLT2 inhibitor on glucose metabolism and body composition in patients with type 2 diabetes - Effects of a SGLT2 inhibitor on glucose metabolism and body composition in patients with type 2 diabetes
Department of Diabetes and Endocrinology Kobe City Medical Center General Hospital0 sites30 target enrollmentNovember 1, 2014
ConditionsType 2 diabetes mellitus
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 2 diabetes mellitus
- Sponsor
- Department of Diabetes and Endocrinology Kobe City Medical Center General Hospital
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Serious infection 2\.Serious liver and/or kidney disease 3\.End stage renal disease with undergoing hemodialysis or peritoneal dialysis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
The effect of SGLT2 inhibitors on glucose and ketone productioEUCTR2015-002094-38-GBniversity of Leicester30
Completed
Not Applicable
The Effect of SGLT2 inhibitors on blood glucose variability in patients with type 1 diabetestype 1 diabetes mellitusJPRN-UMIN000039361Hokkaido University Hospital30
Active, not recruiting
Phase 1
The effect of SGLT2 inhibitors in people with type 2 diabetesEUCTR2016-004878-17-GBniversity of Leicester18
Completed
Not Applicable
Investigation of metabolic change by SGLT2 inhibitors in type 2 diabetes patients.JPRN-UMIN000015057Kitasato University School of Medicine,Endocrinology and Metabolism.20
Completed
Not Applicable
Effect of SGLT2 inhibitor on energy metabolism in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000024822Kyoto University Graduate School of Medicine100